IP Library › Granted Patent US 8,870,909
Granted Patent B2
US 8,870,909 · App. 13/557,068 · Granted Oct 28, 2014

Aneurysm treatment device and method of use

Inventor: Brian J. Cox (Laguna Niguel, CA)
Assignee: MicroVention, Inc.
A61B17/12022A61F2002/065A61B2017/00898A61F2002/823A61B17/12186A61L2300/416A61L2300/418A61B17/12172A61B17/1219A61F2230/0054A61L31/16A61B17/12113A61F2/88A61F2/91A61F2/856A61L31/145A61B17/12118A61L2300/414A61B2017/00867A61B2017/1205A61F2/90
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,870,909
App. No.
13/557,068
Granted
Oct 28, 2014
Kind
B2
Abstract

The present application discloses an apparatus for treating vascular aneurysms and includes a radially expandable substantially cylindrical structure formed from a plurality of support members and defining a plurality of openings, and at least one reactive material strand selectively integrated into the substantially cylindrical structure. The reactive material is configured to assume a non-reacted state and a reacted state. The reactive material in the reacted state is configured to restrict a flow of blood to an aneurysm.

Claims (29)

1. An intra-aneurysmal bridge device, comprising:

a first engagement member having an elongated shape;

a second engagement member having an elongated shape and being located adjacent to said first engagement member so as to cooperatively form a joint;

a body member connected to said first engagement member and said second engagement member;

a reactive material selectively applied to said first engagement member and said second engagement member, wherein expansion of said reactive material is activated a physiological pH for a period of time.

2. The intra-aneurysmal bridge device of claim 1 , wherein said reactive material has a non-reacted state and a reacted state, wherein said reacted state further restricts blood flow to an aneurysm.

3. The intra-aneurysmal bridge device of claim 2 , wherein said reactive material volumetrically expands in said reacted state.

4. The intra-aneurysmal bridge device of claim 3 , wherein said reactive material is a hydrogel.

5. The intra-aneurysmal bridge device of claim 1 , wherein said first engagement member, said second engagement member and said body member are a single, unitary member.

6. The intra-aneurysmal bridge device of claim 1 , wherein said first engagement member and said second engagement member are curved.

7. The intra-aneurysmal bridge device of claim 6 , wherein said first engagement member and said second engagement member are curved toward said body member.

8. The intra-aneurysmal bridge device of claim 1 wherein said intra-aneurysmal bridge is controllably detachable from an elongated delivery apparatus.

9. An intra-aneurysmal bridge device, comprising:

an elongated member having a plurality of curves that form a body region, a first elongated engagement region, a second elongated engagement region, and a reactive material selectively applied to said first elongated engagement region and said second elongated engagement region, wherein expansion of said reactive material is activated by a physiological pH for a period of time;

wherein said first elongated engagement region and said second elongated engagement region are positioned adjacent to each other so as to form a joint.

10. The intra-aneurysmal bridge device of claim 9 , wherein said first elongated engagement region and said second elongated engagement region extend in opposite directions from each other.

11. The intra-aneurysmal bridge device of claim 9 , wherein said reactive material has a non-reacted state and a reacted state, wherein said reacted state further restricts blood flow to an aneurysm.

12. The intra-aneurysmal bridge device of claim 11 , wherein said reactive material volumetrically expands in said reacted state.

13. The intra-aneurysmal bridge device of claim 12 , wherein said reactive material is a hydrogel.

14. The intra-aneurysmal bridge device of claim 9 , wherein said first elongated engagement region and said second elongated engagement region are curved.

15. The intra-aneurysmal bridge device of claim 14 , wherein said first elongated engagement region and said second elongated engagement region are curved toward said body region.

16. A method of aneurysm treatment comprising:

advancing a bridge device within an aneurysm;

engaging an inner surface of said aneurysm with a first elongated portion of said bridge device and a second elongated portion of said bridge device;

maintaining said first elongated portion of said bridge device adjacent said second elongated portion of said bridge device;

causing volumetric expansion of a reactive material disposed on said first elongated portion of said bridge device and said second elongated portion of said bridge device by exposure to a physiological pH for a period of time;

allowing volumetric expansion of said reactive material after said exposure to said physiological pH for said period of time;

reducing blood flow into said aneurysm with said first elongated portion of said bridge device and said second elongated portion of said bridge device.

17. The method of claim 16 , wherein said first elongated portion of said bridge device and said second elongated portion of said bridge device have a radius of curvature of said inner surface of said aneurysm.

Continuity (3)
Continuation 10763975 · Jan 22, 2004
Continuation In Part 09909715 · Jul 20, 2001
Related Publication 20120289993A1 · Nov 15, 2012